Press release
Pyrimethamine Market Size 2023: Global Share, Industry And Report Analysis By 2030 | S&C Electric Company Schneider Electric Schweitzer Engineering Laboratories
Pyrimethamine Market
Get Free Sample link @ https://www.omrglobal.com/request-sample/pyrimethamine-market
Pyrimethamine Tablets USP, 25 mg, a therapeutic equivalent and first-wave generic version of Daraprim (pyrimethamine) Tablets, was launched by Dr. Reddys Laboratories and was authorized by the US Food and Drug Administration (USFDA) in March 2020. The USFDA has authorized this generic version of Daraprim (pyrimethamine) Tablets as the sole AB-rated generic version of Daraprim (pyrimethamine) Tablets.
full report of Pyrimethamine Market available @ https://www.omrglobal.com/industry-reports/pyrimethamine-market
• Market Coverage
• Market number available for - 2024-2030
• Base year- 2023
• Forecast period- 2024-2030
• Segment Covered- By Source, By Product Type, By Applications
• Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
• Inc., and others
Pyrimethamine Market Report
By Type
• Tablets
• Capsules
• Injectables
By Drug
• Daraprim
• Fansidar
By End-User vertical
• Hospitals and Clinics
• Laboratories
• Others
By Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pyrimethamine-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pyrimethamine Market Size 2023: Global Share, Industry And Report Analysis By 2030 | S&C Electric Company Schneider Electric Schweitzer Engineering Laboratories here
News-ID: 3461025 • Views: …
More Releases from orion market research
Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033.
Infrastructure as Code (IaC) Service Market Overview
The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market…
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033.
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview
The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,…
Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033.
Property Management Service Market Overview
The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly…
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033.
5G Chipset Market Overview
The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT…
More Releases for Pyrimethamine
Unraveling the Global Pyrimethamine Market: Trends, Impacts, and Future Insights
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧:
Pyrimethamine, a vital antiparasitic medication, has been a cornerstone in the treatment and prevention of malaria and toxoplasmosis. This blog delves into the intricate dynamics of the global pyrimethamine market, examining its size, share, and the transformative impacts of the COVID-19 pandemic, while also projecting trends up to 2031.
𝐄𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐏𝐲𝐫𝐢𝐦𝐞𝐭𝐡𝐚𝐦𝐢𝐧𝐞:
Pyrimethamine, a dihydrofolate reductase inhibitor, exerts its antiparasitic effects by disrupting the folate metabolism of protozoan parasites such as Plasmodium spp.…
Pyrimethamine Market 2023 Driving Factors Forecast Research 2029
The global pyrimethamine market is expected to grow at a significant CAGR during the forecast period (2023-2029). Pyrimethamine is a protozoan infection treatment drug. It's frequently used as an antimalarial medication (for both treatment and prevention of malaria) as well as to treat Toxoplasma gondii infections, especially when coupled with the sulfonamide antibiotic sulfadiazine in HIV-positive patients. Owing to its resistance to several plasmodium species, pyrimethamine is usually combined with…
Pyrimethamine Market Outlook 2029: Presents Market Insights & Depth Analysis
The global pyrimethamine market is expected to grow at a significant CAGR during the forecast period. Pyrimethamine is a protozoan infection treatment drug. It's frequently used as an antimalarial medication (for both treatment and prevention of malaria) as well as to treat Toxoplasma gondii infections, especially when coupled with the sulfonamide antibiotic sulfadiazine in HIV-positive patients. Owing to its resistance to several plasmodium species, pyrimethamine is usually combined with sulfonamide…
Why the Market for Pyrimethamine May Be Poised to Take Off
Market Research, INC. has recently published a report on Pyrimethamine market which is an essential tool for businesses to gather critical insights about their target markets, competitors, and industry trends. With the increasing complexity of the global business environment, companies need accurate and up-to-date information to make informed decisions and stay ahead of the competition. That's why we are excited to announce the release of our latest market research report,…
Pyrimethamine Market Trends, Business Growth and Major Driving Factors 2028
Pyrimethamine is a medication used for protozoan infections. It is commonly used as an antimalarial drug (for both treatment and prevention of malaria), and to treat Toxoplasma gondii infections, particularly when combined with the sulfonamide antibiotic sulfadiazine when treating HIV-positive individuals. Pyrimethamine is typically given with a sulfonamide and folinic acid due to its resistance against many Plasmodium species. Pyrimethamine has also been found to limit the expression of the…
Pyrimethamine Treatment Market Research Report- Forecast to 2023
Pyrimethamine is a medication used for protozoan infections. It is commonly used as an antimalarial drug (for both treatment and prevention of malaria), and to treat Toxoplasma gondii infections, particularly when combined with the sulfonamide antibiotic sulfadiazine when treating HIV-positive individuals. Pyrimethamine is typically given with a sulfonamide and folinic acid due to its resistance against many Plasmodium species. Pyrimethamine has also been found to limit the expression of the…
